CANCER – TREATMENT – AUSTRALIA

Skin cancer drug developer plans to list

roymorgansocial Leave a comment

Original article by Sally Rose
The Australian Financial Review – Page: 19 : 29-Sep-14

Melbourne-based Ascend Biopharmaceuticals will offer its shares at $A0.35 in an IPO that aims to raise between $A9m and $A11m. Proceeds of the float will be used to finance clinical trials of drugs that are intended to treat skin cancer and breast cancer. Ascend shares are slated to list on the Australian sharemarket on 14 November 2014

CORPORATES
ASCEND BIOPHARMACEUTICALS LIMITED, ONYVAX, ALCHEMIA LIMITED – ASX ACL, AMRAD CORP LIMITED, F HOFFMAN-LA ROCHE LIMITED, F HOFFMAN-LA ROCHE AG, IMMATICS, LODGE CORPORATE PTY LTD, TRANSGENE

Breathing technique to help avoid radiation

roymorgansocial Leave a comment

Original article by Kate Hagan
The Age – Page: 2 : 9-Jul-14

Breast cancer patients receiving radiation treatment have an elevated risk of developing heart problems, of up to 2%, if the tumour is on the left. However, Epworth Hospital in Melbourne has had good results with teaching the women breathing techniques, so that they can stay still while the radiation doses are administered. Oncologist Andrew See says a clinical trial with a control group will be conducted to show whether the approach is worth pursuing

CORPORATES
EPWORTH HOSPITAL